Clinical Trial Update: Lactobacillus in Preventing Infection in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Myelodysplastic Syndrome [NA]

View source ↗

Summary

This clinical trial update indicates the Lactobacillus probiotic study intended to prevent infection in patients undergoing donor stem cell transplantation for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Lactobacillus probiotic (Lactobacillus)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Breast Cancer, Chronic Myeloproliferative Disorders | NA | Status: TERMINATED